Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Pareto8020on Mar 08, 2022 9:21am
192 Views
Post# 34494522

RE:RE:RE:Large Sell Order Still There This Morning

RE:RE:RE:Large Sell Order Still There This MorningThey have been using the terms "watershed" "company changing" "next level" "transformational" for at least 5 years now but at the precipice of any epic event something happens.  The first whitener with Obagi - too expensive to manufacture, protien for extending organ transplantation time didn't work, big mega buyout of TFC167 with quoted numbers in the hundreds if millions foiled by a reorganization and most recently the Phase I for their diabetes gone generic and rendered useless by their useless and ultra slow China partners.  This is a complete reflection of Howard's inexperience and refusal to put his ego aside and put a competent captain at the helm.  He should have been yanked years ago but that's the problem when the foxes are in charge of the henhouse.
<< Previous
Bullboard Posts
Next >>